Biomarkers containing neutrophil gelatinase-associated lipocalin accurately predict hospital acquired AKI
TAIWAN: According to a study that was published in the journal Critical Care, biomarkers comprising neutrophil gelatinase-associated lipocalin (NGAL) had the best predictive accuracy for the incidence of AKI, irrespective of whether the values were adjusted by urinary creatinine. This was especially true in patients who were receiving medical treatment.
Acute kidney injury (AKI) is linked to a higher risk of end-stage renal disease, chronic kidney disease, and long-term detrimental cardiovascular effects. The optimal approach in clinical practice is to identify AKI as early as feasible, correct its cause, and even ameliorate the sequelae due to the absence of effective treatments for decreased kidney function.
Acute kidney injury (AKI) has been predicted by a number of distinct biomarkers; however, their accuracy differs across studies.
The purpose of this research was to assess the quality of the evidence using a pairwise meta-analysis and evaluate the stated predictive accuracy of AKI biomarkers in various clinical scenarios.
For papers published up to August 15, 2022, the researchers examined PubMed, Medline, Embase, and the Cochrane Library. They chose all research articles involving adults (> 18 years) that discussed the prognostic value of damage biomarkers (neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), liver-type fatty acid-binding protein (L-FABP), inflammatory biomarker (interleukin-18 [IL-18]), and stress biomarkers [tissue inhibitor of metalloproteinases-2 [TIMP-2] insulin. 1,803 analyzed abstracts yielded 242 published relevant research, of which 110 studies with 38,725 patients were included in this meta-analysis.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.